This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Harrow’s 8K filing here.
About Harrow
Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.
Recommended Stories
- Five stocks we like better than Harrow
- Which Wall Street Analysts are the Most Accurate?
- GM’s Lithium Americas Deal Positions It for EV Dominance
- Following Congress Stock Trades
- Amazon: Why Analysts Think It’s A Solid Buy Ahead Of Earnings
- The Most Important Warren Buffett Stock for Investors: His Own
- NextEra’s Diverse Business Is Set to Win As Energy Demand Rises
